CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication.
about
Shining a light on intestinal trafficAsbestos-induced cellular and molecular alteration of immunocompetent cells and their relationship with chronic inflammation and carcinogenesisThe role of adenosine signaling in sickle cell therapeuticsRole of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infectionAdvances in sickle cell therapies in the hydroxyurea eraPeptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-gammaIdentification and characterisation of an iron-responsive candidate probioticNKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines.The role of CXCR3 in DSS-induced colitis.CXCL10+ T cells and NK cells assist in the recruitment and activation of CXCR3+ and CXCL11+ leukocytes during Mycobacteria-enhanced colitis.Atorvastatin reduces plasma levels of chemokine (CXCL10) in patients with Crohn's disease.Delayed resolution of acute inflammation in ulcerative colitis is associated with elevated cytokine release downstream of TLR4.Screening of surface markers on rat intestinal mucosa microfold cells by using laser capture microdissection combined with protein chip technology.Stem cells as potential therapeutic targets for inflammatory bowel disease.The role of CXCR3 in the induction of primary biliary cirrhosis.CXCR3-dependent CD4⁺ T cells are required to activate inflammatory monocytes for defense against intestinal infection.Transient inflammatory-like state and microbial dysbiosis are pivotal in establishment of mucosal homeostasis during colonisation of germ-free mice.Critical role for CXC ligand 10/CXC receptor 3 signaling in the murine neonatal response to sepsis.CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications.Enhanced levels of chemokines and their receptors in the colon of microscopic colitis patients indicate mixed immune cell recruitment.Apple polyphenols require T cells to ameliorate dextran sulfate sodium-induced colitis and dampen proinflammatory cytokine expression.Curcumin inhibits interferon-γ signaling in colonic epithelial cells.Chemokine and cytokine levels in inflammatory bowel disease patients.Lactobacillus paracasei and Lactobacillus plantarum strains downregulate proinflammatory genes in an ex vivo system of cultured human colonic mucosaCXCL10-producing mucosal CD4+ T cells, NK cells, and NKT cells are associated with chronic colitis in IL-10(-/-) mice, which can be abrogated by anti-CXCL10 antibody inhibitionTherapeutic efficacy of CXCR3 blockade in an experimental model of severe sepsis.CXCL10 blockade protects mice from cyclophosphamide-induced cystitisThe role of chemokines in intestinal inflammation and cancer.Integrated gut/liver microphysiological systems elucidates inflammatory inter-tissue crosstalk.IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival.Bioactivity-guided identification and cell signaling technology to delineate the immunomodulatory effects of Panax ginseng on human promonocytic U937 cells.Migration and chemokine receptor pattern of colitis-preventing DX5+NKT cells.Mucosal CXCR4+ IgG plasma cells contribute to the pathogenesis of human ulcerative colitis through FcγR-mediated CD14 macrophage activation.Increased expression of CXCR3 axis components and matrix metalloproteinase in pediatric inflammatory bowel disease patients.Differential role of CXCR3 in inflammation and colorectal cancer.The CXC Chemokine Receptor 3 Inhibits Autoimmune Cholangitis via CD8+ T Cells but Promotes Colitis via CD4+ T Cells.IP-10 Promotes Blood-Brain Barrier Damage by Inducing Tumor Necrosis Factor Alpha Production in Japanese Encephalitis.Anti-inflammatory effects of epidermal growth factor on the immature human intestine
P2860
Q26863227-1F1DF4F5-AEAF-442D-BD88-22033C632696Q27000957-5EDCEE84-4B24-41CF-8289-925B947B196DQ27010098-B888F097-5865-4B4F-A87F-19E8A94B90D3Q27490393-228A4120-0228-47F6-B210-0806A50FCECBQ28088552-8743CA29-52B4-4A41-861B-3814F694054FQ28587904-B40F9117-E0A6-43AC-9A63-73CED2E129E8Q28743610-CB75442E-5D64-45D7-B118-AAFB808BF1ADQ30435470-5E2E1706-1BB0-4FA3-B130-AA75567B0714Q31172529-0929B95D-9971-4A7A-9E20-FD1F00241D25Q33340680-C1AD4D04-D866-4C02-8448-68BFDF183549Q33440583-E966A507-ED0A-4ECC-A793-4181DF410FD2Q33548741-97493B5B-F14D-4699-9EDA-C73AF08C582EQ33756249-EA2E2F3C-9200-48A5-A85B-8BCB63B0A0C7Q33975300-3FCBB415-4561-4A13-9B8F-226C3BC77D68Q35008551-BDBD3270-1682-4A77-AC7E-5D4D3040825FQ35018100-DD17A506-C820-4DCB-89BD-FDDEE8F64677Q35063393-9D2EED00-74E7-481A-8C33-2F62CDAC1E14Q35328903-EB65E1F1-E554-4E87-8483-14CF64F310F3Q35469531-EDE805B5-D5AA-4777-898F-7E98BCB73F12Q35534516-9193E657-FE73-4872-9FCB-B0FD873FDE0BQ35609379-463D8461-18D5-4B63-80D0-D700EC3DA656Q35939370-1888E592-EB9C-400B-86B9-597F6F581CA2Q36338594-78C0075E-46B9-4031-84FF-6F6CB0D71A29Q36620029-CAC59AEF-4192-4CB8-93FB-98EB51E9DD77Q36732325-1C59471A-B149-4F02-AE79-7435DA87E479Q36928116-E899C861-9E3B-4C6B-B177-1FBB4056D5E4Q36975105-6970E10F-0D22-4D48-B347-F1DC51B7CBBEQ37455621-0B0FAB10-B583-4618-87AF-CF83B6C24A71Q38698979-734359A4-115A-414D-BCD6-A67CF89EAF27Q38938649-C7A3BC6A-8A38-4F03-8334-41B2C9BD433FQ41951616-774F2F83-62D4-49D7-9D8A-F92AC9E458DAQ43432096-C8D9A85C-1877-4DC1-BEC6-0F6D158E0FDDQ43883492-8490E772-3E14-479D-B177-A9BA8590838AQ54212301-B95E9F9B-2480-482F-82F3-A0860767DEE2Q55131902-841A8EED-F70F-424B-8EDD-64C9EE743B1FQ55263086-A32CDC28-618E-4860-8F97-3D9617558E0BQ55318118-F9156A52-30F5-401A-8AA0-C2E0D784F23FQ57118129-BEF9153D-B354-401B-9994-8E86BC65B443
P2860
CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication.
@en
type
label
CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication.
@en
prefLabel
CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication.
@en
P2093
P1476
CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication.
@en
P2093
Chandrasekar Venkataraman
James W Lillard
Rajesh Singh
Udai P Singh
P304
P356
10.2174/187153007780832109
P577
2007-06-01T00:00:00Z